Literature DB >> 2060063

Biophysical inhibition of synthetic phospholipid-lung surfactant apoprotein admixtures by plasma proteins.

A R Venkitaraman1, J E Baatz, J A Whitsett, S B Hall, R H Notter.   

Abstract

Biophysical activity and inhibition characteristics were studied for a series of synthetic surfactants composed of purified bovine lung surfactant proteins (SP)-B or -C combined with dipalmitoyl phosphatidylcholine (DPPC) and egg-phosphatidylglycerol (PG) in a weight ratio of 80:20:1 DPPC/PG/protein. Surfactant protein preparations included two isolates of SP-B, confirmed by amino terminal sequence analysis, three isolates of SP-C which were free of SP-B by ELISA and Western blot analysis, and two isolates containing both SP-B and -C. In oscillating bubble studies, mixtures of phospholipids with isolates containing pure SP-B or both SP-B and -C lowered surface tension to less than 1 mN/m within 2 min of pulsation at both 1.25 mg/ml and 2.5 mg/ml. Phospholipids combined with isolates of pure SP-C also had substantial activity, lowering surface tension to between 1 mN/m and 3 mN/m depending on the SP-C preparation used. The surface activity of synthetic phospholipid-apoprotein admixtures was decreased significantly by the plasma proteins albumin and fibrinogen, but with varying characteristics depending on the apoprotein preparation involved. At 1.25 mg/ml phospholipid, admixtures containing either isolate of SP-B were inhibited by 10 mg/ml of plasma proteins, as were those with one of the SP-C preparations. However, admixtures containing the two other pure SP-C preparations were not inhibited until 20-50 mg/ml of albumin or fibrinogen were present. The highest resistance to inhibition was shown by admixtures containing one of the apoprotein isolates having both SP-B and -C.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060063     DOI: 10.1016/0009-3084(91)90048-g

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  6 in total

1.  Effect of hydrophobic surfactant peptides SP-B and SP-C on binary phospholipid monolayers. I. Fluorescence and dark-field microscopy.

Authors:  P Krüger; M Schalke; Z Wang; R H Notter; R A Dluhy; M Lösche
Journal:  Biophys J       Date:  1999-08       Impact factor: 4.033

2.  Surfactant abnormalities in infants with severe viral bronchiolitis.

Authors:  P A Dargaville; M South; P N McDougall
Journal:  Arch Dis Child       Date:  1996-08       Impact factor: 3.791

3.  The role of surfactant proteins in DPPC enrichment of surface films.

Authors:  E J Veldhuizen; J J Batenburg; L M van Golde; H P Haagsman
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

Review 4.  The fate of exogenous surfactant in neonates with respiratory distress syndrome.

Authors:  M Hallman; T A Merritt; K Bry
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

Review 5.  Surfactant alteration and replacement in acute respiratory distress syndrome.

Authors:  A Günther; C Ruppert; R Schmidt; P Markart; F Grimminger; D Walmrath; W Seeger
Journal:  Respir Res       Date:  2001-10-12

Review 6.  Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects.

Authors:  W Seeger; A Günther; H D Walmrath; F Grimminger; H G Lasch
Journal:  Clin Investig       Date:  1993-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.